Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia.

ABSTRACT:

SUBMITTER: Castillo JJ 

PROVIDER: S-EPMC6165799 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature